Galiano Gold Presents Path to Annual Gold Production Above 200,000 Ounces From 2029
Bitget2026/11/09 18:29- Galiano Gold maintained 2026 production guidance of 140,000-160,000 ounces, with all-in sustaining costs of US$2,300-US$2,600 per ounce.
- Third-quarter gold production rose 19% quarter over quarter to 40,900 ounces.
- The debt-free balance sheet included US$112.7 million in cash and restricted cash, with a US$75 million undrawn revolving credit facility.
- Higher-grade Nkran ore supports annual production potential exceeding 200,000 ounces from 2029.
- Esaase conversion drilling is complete, with updated mineral resource and reserve estimates expected in the first quarter of 2027.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
The US FDA requires semaglutide, tirzepatide, and other GLP-1 drugs to include new warnings about the risk of eye disease.
NAION is an eye disease that can cause sudden, painless loss of vision, with some patients potentially experiencing permanent visual impairment. The drugs involved include products from Eli Lilly and Novo Nordisk. According to analysts at Citi, the incidence of NAION is relatively low, and given the significant benefits of GLP-1 drugs in weight control and blood sugar management, the actual impact on prescription behavior is expected to be limited. On Monday, the stock prices of Eli Lilly and Novo Nordisk increased, with the news not causing any significant impact on their share prices.
CleanSpark presents fully funded Sandersville project in investor presentation
Forge Nano completes acquisition of HzO
Crypto prices
More
